U.S. NeuroSurgical USNU Stock
U.S. NeuroSurgical Price Chart
U.S. NeuroSurgical USNU Financial and Trading Overview
| U.S. NeuroSurgical stock price | 0.8 USD |
| Previous Close | 0.1 USD |
| Open | 0.1 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.1 - 0.1 USD |
| 52 Week Range | 0.04 - 0.2 USD |
| Volume | 500 USD |
| Avg. Volume | 520 USD |
| Market Cap | 779.22K USD |
| Beta (5Y Monthly) | 0.090492 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.09 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
USNU Valuation Measures
| Enterprise Value | -286781 USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.6944445 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
U.S. NeuroSurgical Stock Price History
| Beta (5Y Monthly) | 0.090492 |
| 52-Week Change | -47.36% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.2 USD |
| 52 Week Low | 0.04 USD |
| 50-Day Moving Average | 0.09 USD |
| 200-Day Moving Average | 0.13 USD |
USNU Share Statistics
| Avg. Volume (3 month) | 520 USD |
| Avg. Daily Volume (10-Days) | 120 USD |
| Shares Outstanding | 7.79M |
| Float | 4.08M |
| Short Ratio | N/A |
| % Held by Insiders | 28.18% |
| % Held by Institutions | 20.12% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -22.052% |
| Return on Equity (ttm) | -62.35% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -1024000 USD |
| Diluted EPS (ttm) | -0.13 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.28M USD |
| Total Cash Per Share (mrq) | 0.16 USD |
| Total Debt (mrq) | 12K USD |
| Total Debt/Equity (mrq) | 0.9 USD |
| Current Ratio (mrq) | 5.263 |
| Book Value Per Share (mrq) | 0.144 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1207000 USD |
| Levered Free Cash Flow (ttm) | -803625 USD |
Profile of U.S. NeuroSurgical
| Country | United States |
| State | MD |
| City | Rockville |
| Address | 2400 Research Boulevard |
| ZIP | 20850 |
| Phone | 301 208 8998 |
| Website | https://www.usneuro.com |
| Industry | Medical Care Facilities |
| Sector(s) | Healthcare |
| Full Time Employees | 3 |
U.S. NeuroSurgical Holdings, Inc., through its subsidiaries, owns and operates stereotactic radiosurgery centers that utilize gamma knife technology. The company's gamma knife is a stereotactic radio surgical device used to treat brain tumors and other malformations of the brain without invasive surgery. U.S. NeuroSurgical Holdings, Inc. was founded in 1993 and is based in Rockville, Maryland.
Q&A For U.S. NeuroSurgical Stock
What is a current USNU stock price?
U.S. NeuroSurgical USNU stock price today per share is 0.8 USD.
How to purchase U.S. NeuroSurgical stock?
You can buy USNU shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for U.S. NeuroSurgical?
The stock symbol or ticker of U.S. NeuroSurgical is USNU.
Which industry does the U.S. NeuroSurgical company belong to?
The U.S. NeuroSurgical industry is Medical Care Facilities.
How many shares does U.S. NeuroSurgical have in circulation?
The max supply of U.S. NeuroSurgical shares is 17.38M.
What is U.S. NeuroSurgical Price to Earnings Ratio (PE Ratio)?
U.S. NeuroSurgical PE Ratio is now.
What was U.S. NeuroSurgical earnings per share over the trailing 12 months (TTM)?
U.S. NeuroSurgical EPS is -0.09 USD over the trailing 12 months.
Which sector does the U.S. NeuroSurgical company belong to?
The U.S. NeuroSurgical sector is Healthcare.